Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways-Reference-Cited by-同舟云学术

Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways

Published:2020-07-21 Issue:4 Volume:42 Page:604-612
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Yu Miao,Fang Zhi-xiao,Wang Wei-wei,Zhang Ying,Bu Zhi-lei,Liu Meng,Xiao Xin-hua,Zhang Zi-lu,Zhang Xing-ming,Cao Yang,Wang Ying-ying,Lei Hu,Xu Han-zhang,Wu Yun-zhao,Liu Wei,Wu Ying-li

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/s41401-020-0455-x.pdf

Reference39 articles.

1. Williams KM, Moore AR, Lucas PJ, Wang J, Bare CV, Gress RE. FLT3 ligand regulates thymic precursor cells and hematopoietic stem cells through interactions with CXCR4 and the marrow niche. Exp Hematol. 2017;52:40–49.

2. Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood. 2000;96:3029–39.

3. Lagunas-Rangel FA, Chavez-Valencia V. FLT3-ITD and its current role in acute myeloid leukaemia. Med Oncol. 2017;34:114.

4. Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209–21.

5. Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–47.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deubiquitinase USP10 promotes osteosarcoma autophagy and progression through regulating GSK3β-ULK1 axis;Cell & Bioscience;2024-09-02

2. Tuning Immune‐Cold Tumor by Suppressing USP10/B7‐H4 Proteolytic Axis Reinvigorates Therapeutic Efficacy of ADCs;Advanced Science;2024-08-29

3. Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression;European Journal of Medicinal Chemistry;2024-06

4. FLT3-Mutated Leukemic Stem Cells: Mechanisms of Resistance and New Therapeutic Targets;Cancers;2024-05-10

5. Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion;Cell Communication and Signaling;2024-05-07